Skip to main content

Find Clinical Trials

Home
Conditions
Rhinitis, Allergic, Perennial

Clinical trial condition

Rhinitis, Allergic, Perennial

Explore clinical trials studying Rhinitis, Allergic, Perennial. Study availability and eligibility vary by location and protocol.

68 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

Rhinitis, Allergic, Perennial trial results

Completed

The Clinical Effects of Montelukast in Patients With Perennial Allergic Rhinitis (0476-265)

NCT00092118

Conditions: Hypersensitivity, Hypersensitivity, Immediate, Immune System Diseases, +7 more
Locations: Not specified

View Trial Details

Completed

Long Term Safety and Efficacy Trial of Beclomethasone Dipropionate - Hydrofluoroalkane (BDP-HFA) 320 mcg in Allergic Rhinitis

NCT00988247

Conditions: Hypersensitivity, Hypersensitivity, Immediate, Immune System Diseases, +8 more
Locations: Teva Clinical Sudy Site Oxford, Alabama, United States

Teva Clinical Study Site Encinitas, California, United States

Teva Clinical Study Site Huntington Beach, California, United States

Teva Clinical Study Site San Diego, California, United States

View all 34 locations

View Trial Details

Completed

Efficacy & Safety of STG320 Sublingual Tablets of HDM Allergen Extracts in Adults and Adolescents With HDM-associated AR

NCT02443805

Conditions: Dust Mite Allergy, House Dust Mite Allergy, Hypersensitivity, +9 more
Locations: University of South of Florida Tampa, Florida, United States

CHU Arnaud de Villeneuve Montpellier, France

View Trial Details

Completed

Efficacy of Allergen Immunotherapy for Allergic Rhinitis in Thais

NCT01115595

Conditions: Hypersensitivity, Hypersensitivity, Immediate, Immune System Diseases, +7 more
Locations: Division of Allergy and Rhinology, Faculty of Medicine Siriraj, Mahidol University Bangkok, Thailand

View Trial Details

Completed

Short and Mid-term Repeatability of Active Anterior Rhinomanometry (AAR) Measurements in Paediatric Age

NCT03286049

Conditions: Hypersensitivity, Hypersensitivity, Immediate, Immune System Diseases, +10 more
Locations: Institute of Biomedicine and Molecular Immunology (IBIM), National Research Council Palermo, Sicily, Italy

View Trial Details

Completed

Single Dosing Clinical Trial of HL151

NCT02682745

Conditions: Hypersensitivity, Hypersensitivity, Immediate, Immune System Diseases, +7 more
Locations: The Korea Univertisy Anam Hospital Seoul, South Korea

View Trial Details

Completed

Repeated Dosing Clinical Trial of HL151

NCT02686294

Conditions: Hypersensitivity, Hypersensitivity, Immediate, Immune System Diseases, +7 more
Locations: The Korea Univertisy Anam Hospital Seoul, South Korea

View Trial Details

Completed

Effectivness and Safety of Acupuncture Combined With Moxibustion for Allergic Rhinitis

NCT02339714

Conditions: Hypersensitivity, Hypersensitivity, Immediate, Immune System Diseases, +7 more
Locations: Guang'anmen Hospital, China Academy of Chinese Medical Sciences Beijing, Beijing Municipality, China

Institute of Acupuncture and Moxibustion, China Academy of Chinese Medical Sciences Beijing, Beijing Municipality, China

Mentougou Hospital of TCM Beijing, Beijing Municipality, China

View Trial Details

Completed

Once-Daily Investigational Nasal Spray In Adults And Adolescents With Perennial Allergic Rhinitis (PAR)

NCT00289198

Conditions: Hypersensitivity, Hypersensitivity, Immediate, Immune System Diseases, +7 more
Locations: GSK Investigational Site San Diego, California, United States

GSK Investigational Site Baltimore, Maryland, United States

GSK Investigational Site Wheaton, Maryland, United States

GSK Investigational Site North Dartmouth, Massachusetts, United States

View all 42 locations

View Trial Details

Completed

Fluticasone Nasal Spray Patient Preference Study

NCT00398476

Conditions: Hypersensitivity, Hypersensitivity, Immediate, Immune System Diseases, +7 more
Locations: GSK Investigational Site Fountain Valley, California, United States

GSK Investigational Site Long Beach, California, United States

GSK Investigational Site San Diego, California, United States

GSK Investigational Site Denver, Colorado, United States

View all 14 locations

View Trial Details